News for Healthier Living

Denosumab Increases Risk of Emergently Treated Hypocalcemia in Advanced Chronic Kidney Disease

A target trial emulation evaluated the incidence of emergently treated hypoalcemia associated with denosumab by stage of chronic kidney disease (CKD) progression and presence of CKD-mineral and bone disorder (CKD-MBD).

November 18, 2024


November 19 2024

November 18 2024

November 17 2024

November 16 2024

November 15 2024

November 14 2024

November 13 2024

November 12 2024

November 11 2024

November 10 2024

November 9 2024

November 8 2024

November 7 2024

November 6 2024

November 5 2024